Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
about
The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of AtherosclerosisChlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureMatrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.Vaccination and atherosclerosis.Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cellsTelithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J micePossibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat modelChlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis.Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).Chlamydia pneumoniae and Cardiovascular Disease.
P2860
Q28077737-3F876E6B-3DD5-402D-BB67-DC9C22DB6C93Q34130686-D29A0A69-B960-455F-ABF9-B64EF9765DA6Q35127516-366BA986-757C-469F-AAD3-0AD85DAD0CD4Q35583908-AE312CB0-FBCC-4FA8-8E65-98A998F1D959Q35692035-1E81C2EE-F2CC-4774-B070-3D68B7DD64C8Q35701591-D3D3EE82-3200-4932-AC00-7A6CBED9661EQ35758705-89F2B9E1-EFE2-4760-8AD6-A6F92197F19BQ37196471-875CB0A2-19C6-431C-951E-C56E7062D150Q37295072-8E098B9D-139A-4820-80C9-4C96150C4BBDQ37568474-C696BBB3-1F77-4DF5-8AAE-4B6FB492252CQ37775097-A539B0A7-F418-4AFD-96A2-00F37C0DB66AQ37868385-03C3D657-3C45-44DE-92D7-F1660D407EC3Q37870129-479F73D3-99EE-4F80-9DD6-846615926E84Q37870924-C0750D4B-A384-4253-AF41-CC4E365F0E8DQ51726841-765231CA-999F-4996-BBAF-82649AB8EF12
P2860
Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@en
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@nl
type
label
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@en
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@nl
prefLabel
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@en
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@nl
P2093
P356
P1476
Chlamydia pneumoniae does not ...... olipoprotein E-deficient mice.
@en
P2093
Aalto-Setälä K
Jauhiainen M
Laitinen K
Leinonen M
Penttilä I
Puolakkainen M
Tamminen M
P304
P356
10.1161/01.ATV.21.4.578
P407
P577
2001-04-01T00:00:00Z